This live coverage has ended. For the latest coronavirus news, click here.
Albert Bourla, Pfizer’s chief executive, had projected that a fourth dose might be needed 12 months after a third shot. But he said on CNBC’s “Squawk Box” that the timeline might need to be moved up. One of the company’s top scientists recently said a fourth shot — possibly one targeting omicron — is likely to be necessary.